Valuation Harmony Biosciences Holdings, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-10 pm EST			5-day change	1st Jan Change
39.27 ^USD	+1.16%		+9.05%	+14.12%

Dec. 08	Harmony Biosciences Holdings, Inc. Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome	CI
Dec. 01	Mizuho Raises Price Target on Harmony Biosciences Holdings to $46 From $39, Keeps Outperform Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	2,057	2,493	3,268	1,892	1,962	2,262	-	-
Change	-	21.23%	31.09%	-42.12%	3.73%	15.25%	-	-
Enterprise Value (EV) ¹	2,022	2,449	3,214	1,759	1,689	1,691	1,402	1,020
Change	-	21.1%	31.25%	-45.28%	-3.98%	0.14%	-17.09%	-27.27%
P/E ratio	-14.6x	73.5x	18.6x	15.2x	13.7x	12.5x	9.66x	8.31x
PBR	-	-	-	-	2.98x	2.58x	1.95x	1.47x
PEG	-	-1x	0x	-0.5x	0.8x	0.5x	0.3x	0.5x
Capitalization / Revenue	12.9x	8.16x	7.46x	3.25x	2.75x	2.62x	2.26x	2x
EV / Revenue	12.7x	8.02x	7.34x	3.02x	2.36x	1.96x	1.4x	0.9x
EV / EBITDA	74.2x	23x	22.4x	8.13x	7.86x	6.59x	4.27x	2.73x
EV / EBIT	119x	28x	26.7x	9.16x	8.85x	6.9x	4.32x	2.77x
EV / FCF	-677x	24.9x	22.3x	8.03x	7.72x	6.33x	5.44x	3.51x
FCF Yield	-0.15%	4.01%	4.49%	12.5%	12.9%	15.8%	18.4%	28.5%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.48	0.58	2.97	2.13	2.51	3.153	4.063	4.726
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	159.7	305.4	437.9	582	714.7	862.7	1,002	1,131
EBITDA ¹	27.26	106.4	143.6	216.4	214.9	256.6	328.2	373.2
EBIT ¹	16.99	87.53	120.2	192	190.8	245.1	324.9	368
Net income ¹	-63.85	34.6	181.5	128.9	145.5	192.2	249.5	284.8
Net Debt ¹	-34.38	-44.32	-54.14	-133.1	-273.7	-570.7	-859.7	-1,242
Reference price ²	36.15	42.64	55.10	32.30	34.41	39.26	39.26	39.26
Nbr of stocks (in thousands)	56,889	58,472	59,318	58,572	57,031	57,596	-	-
Announcement Date	3/25/21	2/28/22	2/21/23	2/22/24	2/25/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
HARMONY BIOSCIENCES HOLDINGS, INC.	12.31x	1.93x	6.49x	-.--%	2.24B
ELI LILLY AND COMPANY	42.94x	14.23x	31.57x	0.6%	879B
JOHNSON & JOHNSON	19.08x	5.36x	14.83x	2.58%	482B
ABBVIE INC.	52.09x	7.39x	17.5x	2.93%	394B
ROCHE HOLDING AG	18.3x	4.6x	11.51x	3.13%	335B
ASTRAZENECA PLC	27.25x	5.16x	15.31x	1.78%	281B
NOVARTIS AG	18.3x	4.95x	11.64x	3.08%	254B
MERCK & CO., INC.	12.52x	4.1x	8.77x	3.34%	240B
NOVO NORDISK A/S	12.97x	4.66x	9.65x	3.89%	207B
AMGEN INC.	23.98x	5.88x	10.1x	3.04%	169B
Average	23.97x	5.83x	13.74x	2.44%	324.38B
Weighted average by Cap.	29.50x	7.77x	18.11x	2.28%